BioStock: PolarCool´s CEO on the goals for 2023

2022 has been somewhat of a breakthrough year for medtech company PolarCool and their PolarCap System, a medical cooling device intended to reduce concussion symptoms and improve recovery after a head injury. The company advanced on several fronts. Not only did new scientific data clinically confirm the technology's positive effect, but the company also entered into several agreements and received orders from elite sport clubs. BioStock contacted CEO Erik Andersson for a comment on the progress made during 2022, and the goals for 2023.

Read the interview with Erik Andersson at biostock.se:

PolarCool´s CEO on the goals for 2023 - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/